Therapeutic actions of α-human atrial natriuretic polypeptide in 16 clinical cases

This publication has 13 references indexed in Scilit:

• Alpha-human atrial natriuretic polypeptide (Alpha-hANP) in normal volunteers and patients with heart failure or hypertension
  Peptides, 1986
• Effects of alpha-human atrial natriuretic peptide in essential hypertension.
  Hypertension, 1985
• RENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERS
  The Lancet, 1985
• Atrial Natriuretic Factor Inhibits Dehydration and Hemorrhage-Induced Vasopressin Release
  Neuroendocrinology, 1985
• Depressor and natriuretic activities of several atrial peptides
  Regulatory Peptides, 1984
• What is the value of home blood pressure measurement in patients with mild hypertension?
  Hypertension, 1984
• An atrial peptide is a potent renal vasodilator substance.
  Circulation Research, 1984
• Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)
  Biochemical and Biophysical Research Communications, 1984
• Bioactive Cardiac Substances: Potent Vasorelaxant Activity in Mammalian Atria
  Science, 1983
• Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects¹
  Journal of Clinical Endocrinology & Metabolism, 1969